Skip to main content

Month: March 2025

Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs

All resolutions approved by bondholders Closing of Royalty Financing and receipt of first €130 million instalment expected shortly Upon closing of the Royalty Financing, GENFIT will implement the Repurchase of the 2025 OCEANEs and pay the Consent FeeLille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), March 10, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases (the “Company”), today announces the results of the bondholders’ vote at the general meeting of the 2025 OCEANEs holders which took place this Monday, March 10, 2025 at 2:30pm (Paris time): all resolutions proposed by the Company were approved. General meeting of the 2025 OCEANEs holders The terms and conditions of the 2025 OCEANEs...

Continue reading

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Mont-Saint-Guibert, Belgium – Monday, March 10, 2025, 10:05pm CET / 5:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the fourth quarter and financial year 2024 on Thursday, March 13, 2025. Company management will host a conference call to discuss financial results that day beginning 1:00pm CET / 8:00am ET. A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah’s Q4 and FY 2024 Earnings Call Webcast. For those not planning to ask a question of management, the Company...

Continue reading

Parker Scheduled to Present at the Bank of America Global Industrials Conference on March 19 at 10:35 a.m. Greenwich Mean Time (6:35 a.m. Eastern Time)

CLEVELAND, March 10, 2025 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Bank of America Global Industrials Conference in London, England on March 19, 2025 at 10:35 a.m. Greenwich Mean Time (6:35 a.m. Eastern Time). A live webcast of the presentation will be accessible on Parker’s investor information website at investors.parker.com and will be archived on the site.  Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For more than a century the company has been enabling engineering breakthroughs that lead to a better tomorrow. Parker has increased its annual dividend per share paid to shareholders for 68 consecutive fiscal years, among the top five longest-running dividend-increase...

Continue reading

Helium Evolution Announces $2.7 Million Financing and Strategic Partnership with ENEOS Xplora Inc., Subsidiary of ENEOS Group

NOT FOR DISTRIBUTION IN THE UNITED STATES CALGARY, Alberta, March 10, 2025 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is very pleased to announce a strategic partnership with ENEOS Xplora Inc. (“ENEOS Xplora”) through its affiliated company, ENEOS Xplora USA Limited (“ENEOS USA”). ENEOS Xplora and ENEOS USA are both wholly owned subsidiaries of ENEOS Group, Japan’s largest energy, resources and materials conglomerate with current revenue of $91 billion USD. This transaction marks a major milestone for HEVI, underscoring the Company’s growth trajectory and strategic positioning in the helium sector. The transaction with ENEOS USA includes an investment agreement (the...

Continue reading

Viemed Healthcare Announces Record 2024 Financial Results

LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD):Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended December 31, 2023. Total net revenues for the year ended December 31, 2024 were a record-breaking $224.3 million, an increase of $41.2 million, or 23%, over...

Continue reading

Sword Group: Sword Switzerland strengthens its position with UN agencies | 4th framework contract signed with the WHO

A new strategic step for Sword Switzerland | Objective of +50% growth in the UN market by 2025 Sword has reached a new milestone with the signing of its fourth framework contract with a major UN agency: the World Health Organisation (WHO). This success confirms our Swiss division’s strategy of development and excellence in the international organisations market. This new 5-year contract confirms our long-term presence and commitment. An organisation optimised to serve the UN market:– Specialised business unit for UN agencies,– Global processes encouraging international collaboration within the group,– Nearshore and offshore delivery centres,– Innovative service models such as Centres of Expertise (Microsoft 365),– Local presence in Geneva, close to the UN offices. Global reach and increased opportunities:...

Continue reading

Apexis, Inc. dba Wondersign, a GigaCloud Company, Launches Wonder App and Is Set to Rebrand as Wonder

Redefining Sales Enablement for Suppliers and Retail Sales Associates in the Brick-and-Mortar Market Ashley Furniture Leads as First Adopter EL MONTE, Calif., March 10, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc. (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that its subsidiary, Apexis, Inc., has launched the Wonder App—a mobile-first, lightweight sales acceleration platform designed for brick-and-mortar commerce. The app connects suppliers and retail sales associates (RSAs) by offering education, training, performance tracking and rewards, providing suppliers with instant insights into RSA activity and greater sales influence. “Brick-and-mortar retail is evolving rapidly, and suppliers must stay connected to their...

Continue reading

Belpointe OZ Announces Fourth Quarter 2024 Net Asset Value Per Class A Unit

GREENWICH, Conn., March 10, 2025 (GLOBE NEWSWIRE) — Belpointe PREP, LLC (NYSE American: OZ) (“Belpointe OZ,” “we,” “us,” “our” or the “Company”), a publicly traded qualified opportunity fund, today announced its unaudited quarterly net asset value (“NAV”) as of December 31, 2024, of $439,479,873 or $119.94 per Class A Unit. The approximately $22 increase in our unaudited quarterly NAV, from $97.93 as of September 30, 2024 to $119.94 as of December 31, 2024, is primarily due to updated valuations for Belpointe OZ’s Florida assets, reflecting continued progress across our portfolio. “Our flagship development, Aster & Links in Sarasota, FL, is making solid lease-up progress, contributing significantly to our increased valuation,” said Brandon Lacoff, CEO of Belpointe OZ. “Additionally, Viv, our development in St. Petersburg,...

Continue reading

Disclosure of transactions in on shares from March 03rd to March 07th, 2025

Nanterre, March 10th, 2025                       Disclosure of transactions in on shares from March 03rd to March 07th, 2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 09, 2024, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from March 03rd to March 07th, 2025: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 2025-03-03 FR0000125486 37 107 110,613290 XPARVINCI 2025-03-03 FR0000125486 19 586 111,062815 CEUXVINCI 2025-03-03 FR0000125486 11...

Continue reading

Quanex Building Products Announces First Quarter 2025 Results and Reaffirms Full Year 2025 Guidance

Margin Expansion Realized on Consolidated BasisResults Lifted by Contribution from Tyman AcquisitionRealization of Cost Synergies from Tyman Acquisition Progressing Well$65 Million of Debt Repaid Since Closing Tyman Acquisition HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2025.   The Company reported the following selected financial results:    Three Months Ended January 31,($ in millions, except per share data)   2025   2024Net Sales   $400.0   $239.2Gross Margin   $92.3   $51.4Gross Margin %   23.1%   21.5%Net (Loss) Income   ($14.9)   $6.2Diluted EPS   ($0.32)   $0.19         Adjusted Net Income   $9.0   $8.4Adjusted Diluted EPS   $0.19   $0.25Adjusted EBITDA   $38.5   $19.3Adjusted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.